Lincoln Pharmaceuticals Limited
BSE: LINCOPH.BO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Bombay Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- India
- IPO year
- 2002
- Market cap
- ₹12.8B
Loading LINCOPH…
Loading profile data…Frequently asked questions about LINCOPH
What does Lincoln Pharmaceuticals Limited (LINCOPH.BO) do?
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company provides products in the areas of cough and cold, anti-allergic, and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins, minerals, and antioxidants; anti-bacterial, anti-viral,...
Where does LINCOPH.BO trade?
Lincoln Pharmaceuticals Limited (LINCOPH.BO) trades on the Bombay Stock Exchange.
What sector is LINCOPH.BO in?
Lincoln Pharmaceuticals Limited (LINCOPH.BO) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Where is Lincoln Pharmaceuticals Limited headquartered?
Lincoln Pharmaceuticals Limited is headquartered in India.
Does LINCOPH.BO pay a dividend?
Yes — Lincoln Pharmaceuticals Limited (LINCOPH.BO) paid a trailing twelve-month dividend of INR 1.50 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did LINCOPH.BO go public?
Lincoln Pharmaceuticals Limited (LINCOPH.BO) completed its initial public offering in 2002.